Moneycontrol PRO
Upcoming Webinar:Prashant Shah explains ‘Irrelevance of Bull & Bear Markets for Success in Technical Analysis’. Register For Free!
you are here: HomeNewsIndia

COVID-19 | Centre lifts ban on Remdesivir export, allows overseas sale sans authorisation

The export of Remdesivir injections and APIs against the Advance Authorization shall no longer require a separate export authorisation or permission as, under the revised policy, the drug has been moved from 'prohibited' to 'restricted' category.

June 15, 2021 / 07:23 AM IST
Source: Reuters

Source: Reuters

Government of India on June 14 amended the export policy for injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) and allowed 'restricted' export of the drug used in COVID-19 treatment with immediate effect.

In a notification issued on June 14, the Ministry of Commerce and Industry said: "The Central Government hereby amends the notification dated 11.04.2021 related to the export of injection Remdesivir and Remdesivir API."

The export of Remdesivir injections and APIs against the Advance Authorization shall no longer require a separate export authorisation or permission as, under the revised policy, the drug has been moved from 'prohibited' to 'restricted' category.

Centre's notification added: "The export of injection Remdesivir and Remdesivir API has been put under restricted category with immediate effect."

Notably, in the wake of the second wave of the pandemic, when COVID-19 cases had increased sharply, the Centre, on April 11, had halted the export of Remdesivir injection and API. At the time, there was a growing demand for Remdesivir injections in the country.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Government of India had said: "Export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) prohibited till the COVID-19 situation in the country improves."

Follow our coverage of the coronavirus crisis here
Moneycontrol News
first published: Jun 14, 2021 09:39 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark